Welcome to the
Galenica network.

Our ambition is to meet the needs of patients and customers in the Swiss healthcare market in a seamless, efficient and personalised way. To achieve this, we operate the Galenica network with over 20 Business Units, the strongest partners in the Swiss healthcare market.

Half year report 2024: A strong network for Switzerland

Despite the challenging market environment in the first half of 2024, we achieved solid sales growth of 2.6% and thus gained market shares.

Perspectives in the Galenica network

Man looks satisfied and crosses his hands
Man looks satisfied and crosses his hands

Galenica reports strong sales growth once again

Galenica Group sales once again performed very positively in 2024, with growth of 4.7% to CHF 3,922 million. As a result, Galenica outperformed the entire pharmaceutical market in terms of growth (+3.5%, IQVIA, Pharmaceutical Market Switzerland, YTD December 2024).

Two business women talk to each other
Two business women talk to each other

Galenica nominates Nadine Balkanyi-Nordmann for the Board of Directors

Nadine Balkanyi-Nordmann, an experienced legal, compliance and governance expert, will be recommended for election as a member of the Board of Directors at the next Annual General Meeting of the Galenica Group.

Neues Führungsduo für Medifilm
Neues Führungsduo für Medifilm

Patrick Rindlisbacher and Martin Recknagel now jointly manage Medifilm

This top-sharing approach allows the two co-managers to make the best possible use of their respective expertise and thus prepare Medifilm for the next phase of growth.

Corporate
Information

Galenica (SIX Swiss Exchange)

Aktueller Kurs

79.90 CHF

Volume

15,570.00

01/24/2025 10:18

Marc Werner, CEO

«We have embedded our network philosophy even more firmly into our strategy. Clients will benefit from a comprehensive range of services from a single source.»

Marc Werner, CEO

Contact inquiries

Galenica Ltd.
Untermattweg 8
3027 Bern

Footer